Tesamorelin/Ipamorelin
Synergistic growth hormone support.
A synergistic combination of Tesamorelin and Ipamorelin for enhanced growth hormone optimization with complementary mechanisms of action.
How it works
Tesamorelin stimulates GH release via GHRH pathway while Ipamorelin acts as a selective ghrelin mimetic, together amplifying natural GH pulsatility without cortisol or prolactin elevation.
Benefits
- Stimulates natural growth hormone release
- Once-daily dosing
- Physician-dosed
- Does not replace hormone directly
Dosing protocol
Daily subcutaneous injection before bedtime. Provider-guided dosing.
Contraindications
- Active cancer
- Pregnancy
- Pituitary disorders
Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality. Medications only issued when clinically appropriate after provider evaluation.